SCHEMBL16443387

SCHEMBL16443387

CN(c1ccc(Oc2cccc(Cl)c2)c(/C=C/C(=O)NO)c1)c1ccccn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.46
▸ HDAC8 Q9BY41 7/20 0.45
▸ HDAC6 Q9UBN7 4/20 0.45
▸ HDAC11 Q96DB2 2/20 0.45
▸ TUBB4A P04350 1/20 0.44
▸ TUBB P07437 1/20 0.44
▸ TUBA3C P0DPH7 1/20 0.44
▸ TUBA1B P68363 1/20 0.44
▸ TUBA4A P68366 1/20 0.44
▸ TUBB4B P68371 1/20 0.44
▸ TUBB3 Q13509 1/20 0.44
▸ TUBB2A Q13885 1/20 0.44
▸ TUBB8 Q3ZCM7 1/20 0.44
▸ TUBA3E Q6PEY2 1/20 0.44
▸ TUBA1A Q71U36 1/20 0.44
▸ TUBA1C Q9BQE3 1/20 0.44
▸ TUBB6 Q9BUF5 1/20 0.44
▸ TUBB2B Q9BVA1 1/20 0.44
▸ TUBB1 Q9H4B7 1/20 0.44
▸ HDAC1 Q13547 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16443485 0.89 HDAC8 (0.46) HDAC8HDAC6HDAC11TUBB4ATUBB
SCHEMBL16443577 0.89 HDAC8 (0.45) HDAC8HDAC6HDAC11TUBB4ATUBB
SCHEMBL16443422 0.85 HDAC8 (0.47) HDAC8HDAC6HDAC11TUBB4ATUBB
SCHEMBL16443333 0.84 GRM5 (0.45) LMNAHDAC8HDAC6HDAC11TUBB4A
SCHEMBL15066373 0.77 LMNA (0.74) LMNAHDAC8HDAC6HDAC1PTGER3
SCHEMBL15066376 0.77 LMNA (0.74) LMNAHDAC8HDAC6HDAC1PTGER3
SCHEMBL15065752 0.77 LMNA (0.46) LMNAHDAC8HDAC6HDAC11HDAC1
SCHEMBL15088661 0.77 LMNA (0.46) LMNAHDAC8HDAC6HDAC11HDAC1
SCHEMBL15065367 0.74 LMNA (0.51) LMNAHDAC8HDAC6HDAC1MAPT
SCHEMBL15065495 0.74 LMNA (0.51) LMNAHDAC8HDAC6HDAC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150045367-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 PHARMACYCLICS LLC 2015-02-12 — — US claimed
US-20150045367-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 PHARMACYCLICS LLC 2015-02-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150045367-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 HDAC8, HDAC5, HDAC7 LMNA 537/4885HDAC8 1/4885HDAC6 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback